TAG Theater
Kay Durairaj, MD, FACS
CEO – Beauty By Dr. Kay
K. Kay Durairaj, M.D., F.A.C.S., A Medical Corp.
Pasadena, CA, United States
Derrick DeSilva, Jr., MD
Owner Derrick DeSilva, Jr., MD LLC
Teaching Faculty JFK Med Ctr, Edison, NJ
Assoc Attending Staff RBMC, Perth Amboy, NJ
Edison, NJ, United States
Samantha Thiry, ARNP, FNP-C
Founder
Happy Body ATX
Austin, TX, United States
Azza Halim, MD
Medical Director
RegenerativeAestheticsMD
Boca Raton, FL, United States
Peptides are rapidly moving beyond medical weight loss and into broader conversations around aesthetics, longevity, recovery, and regenerative medicine. As practices look for ways to address GLP-1-related skin laxity, facial volume loss, recovery, and overall patient optimization, peptides are increasingly being considered as part of combination treatment strategies. This session explores how practitioners are evaluating peptide therapies, integrating them alongside injectables, energy-based devices, regenerative treatments, and wellness programs, and determining where peptides may offer meaningful clinical value. The discussion will also examine patient demand, compliance considerations, and whether peptides are poised to become a lasting component of aesthetic medicine or simply the industry's next trend.
